POLE and glioblastoma: At 10 h after BrdU treatment, the relative subpopulation of mid-S phase BrdU-positive cells was significantly increased in POLE KO versus WT cells (two-tailed Student’s t test, p = 0.0073), suggesting delayed S phase progression in POLE KO LN-229 glioblastoma cells (Fig. 5d, e).